Zepbound is the preferred weight loss medicine vs. Wegovy and has consistently beaten the latter in U.S. weekly prescriptions ...

Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to ...

Not long ago the largest company by market capitalization in Europe, the evolution of the weight loss medicine market has ...

CompanyOverview|NYSE:LLY] The world’s largest pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), recently had its worst ...

Zepbound, Lilly’s obesity drug, has overtaken Novo’s equivalent, Wegovy, in the US and now commands over 50 per cent of the ...

From a technical perspective, FTAI Aviation (FTAI) is looking like an interesting pick, as it just reached a key level of support. FTAI recently overtook the 20-day moving average, and this suggests a ...